ask="2.34"
ask_size="12500"
average_daily_volume="396360"
bid="2.20"
bid_size="500"
book_value="4.01"
change="+0.01"
change_from_200_day_moving_average="-3.15"
change_from_50_day_moving_average="-0.70"
change_from_52_week_high="-7.13"
change_From_52_week_low="0.22"
change_in_percent="+0.45%"
close="2.22"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.96"
ebitda="-30.59M"
eps_estimate_current_year="-2.08"
eps_estimate_next_quarter="-0.53"
eps_estimate_next_year="-1.69"
ex_dividend_date="N/A"
float_shares="8428000"
high="2.28"
high_52_weeks="9.35"
last_trade_date="1/13/2017"
last_trade_price="2.22"
last_trade_size="260"
last_trade_time="4:00pm"
low="2.16"
low_52_weeks="2.00"
market_capitalization="34.51M"
moving_average_200_day="5.37"
moving_average_50_day="2.92"
name="Nivalis Therapeutics
Inc."
notes="N/A"
one_year_target_price="12.08"
open="2.28"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-58.69%"
percent_change_from_50_day_moving_average="-24.03%"
percent_change_from_52_week_high="-76.26%"
percent_change_from_52_week_low="+11.00%"
previous_close="2.21"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.55"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="15543000"
short_ratio="0.40"
stock_exchange="NGM"
symbol="NVLS"
volume="1335287"
weeks_range_52="2.00 - 9.35"
